首页> 外文期刊>Wuhan University Journal of Natural Sciences >Regulations in thyroid hormone on cardiac protein kinase C signal pathway in vitro
【24h】

Regulations in thyroid hormone on cardiac protein kinase C signal pathway in vitro

机译:甲状腺激素对体外心脏蛋白激酶C信号通路的调节

获取原文
获取原文并翻译 | 示例
       

摘要

The experiments were conducted to assess the influences of thyroid hormone on cardiac protein kinase C(PKC) signal pathway with cultured cardiac myocytes and fibroblasts as the models. Cells were pretreated with 1 % newborn calf serum (NCS) or angiotensin II (Ang II), and then following by a triiodothyronine (T3) treatment. The PKC activity, PKCalpha and PKCepsilon expressions were analyzed and compared. In 1 % NCS pretreatment, T3 could inhibit PKC activity and PKCepsilon expression in cardiac myocytes. The AngII pretreatment led to an increase of PKC activity and PKCepsilon expression in cardiac myocytes, and an increase of PKC activity in cardiac fibroblasts. Following by T3 treatment, the increased PKC activity and PKCepsilon expression in cardiac myocytes were markedly decreased. In conclusion, whether in 1 % NCS or in Ang II pretreatment, T3 could inhibit PKC activity and PKCepsilon expression in cardiac myocytes.
机译:以培养的心肌细胞和成纤维细胞为模型,评估了甲状腺激素对心脏蛋白激酶C(PKC)信号通路的影响。用1%新生小牛血清(NCS)或血管紧张素II(Ang II)预处理细胞,然后进行三碘甲状腺素(T3)处理。分析并比较了PKC活性,PKCalpha和PKCepsilon表达。在1%NCS预处理中,T3可以抑制心肌细胞中PKC活性和PKCepsilon表达。 AngII预处理导致心肌细胞中PKC活性和PKCepsilon表达增加,以及心脏成纤维细胞中PKC活性增加。经过T3处理后,心肌细胞中PKC活性和PKCepsilon表达的增加明显降低。总之,无论在1%NCS中还是在Ang II预处理中,T3均可抑制心肌细胞中PKC活性和PKCepsilon表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号